Maravai Lifesciences Holdings Inc (OQ:MRVI)

Jan 08, 2025 04:10 pm ET
Maravai LifeSciences Announces Preliminary Unaudited 2024 Revenue
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that based on preliminary year-end results and subject to year-end closing...
Dec 05, 2024 04:05 pm ET
Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors
Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced that Carl Hull will retire from his position as Executive...
Nov 12, 2024 08:05 am ET
Maravai LifeSciences Announces November 2024 Investor Conference Schedule
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conferences in November. On November 19, 2024, at 8:30...
Nov 07, 2024 04:01 pm ET
Maravai LifeSciences Plans to Acquire DNA and RNA Business of Officinae Bio, Advancing Support for Innovative Nucleic Acid Research
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced that it has signed an agreement to acquire the DNA and RNA business of
Nov 07, 2024 04:01 pm ET
Maravai LifeSciences Reports Third Quarter 2024 Financial Results
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the third quarter ended September 30, 2024, together...
Oct 15, 2024 04:05 pm ET
Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024
Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its third quarter 2024 financial and operating results after the market closes on...
Sep 24, 2024 08:12 am ET
TriLink BioTechnologies® & Alphazyme Collaborate to Launch New CleanScribe™ RNA Polymerase
TriLink BioTechnologies and Alphazyme, both part of Maravai LifeSciences, have collaborated to
Aug 28, 2024 07:49 am ET
Aug 12, 2024 08:05 am ET
Maravai LifeSciences Announces August and September 2024 Investor Conference Schedule
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conferences in August and September. On August 14,...
Aug 07, 2024 04:05 pm ET
Maravai LifeSciences Reports Second Quarter 2024 Financial Results
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the second quarter ended June 30, 2024, together with...
Jul 29, 2024 04:05 pm ET
Maravai LifeSciences Appoints Trey Martin to Board of Directors
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced that its CEO William “Trey” Martin, III has been appointed to the Company’s Board of Directors,...
Jul 10, 2024 08:00 am ET
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, August 7, 2024
Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter 2024 financial and operating results after the market closes on...
Jul 02, 2024 04:00 pm ET
Maravai Lifesciences Releases 2023 Environmental, Social and Governance (ESG) Report
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced the release of its 2023 Environmental, Social and Governance (ESG) report,...
May 13, 2024 08:00 am ET
TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center
TriLink BioTechnologies (TriLink®), a Maravai™ LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, is collaborating with the Johns Hopkins University to accelerate transformational research in RNA therapeutics and discovery. A new center within the Johns Hopkins Whiting School of Engineering wi
May 09, 2024 04:05 pm ET
Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conference during the months of May and June. On May...
May 08, 2024 04:05 pm ET
Maravai LifeSciences Reports First Quarter 2024 Financial Results
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the first quarter ended March 31, 2024, together with...
Apr 30, 2024 07:31 am ET
TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
TriLink BioTechnologies (TriLink®), a Maravai™ LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has signed a non-exclusive License and Supply Agreement with Lonza, a global development and manufacturing partner to the pharma, biotech and nutrition industries. This agreement with L
Apr 18, 2024 07:36 am ET
TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production
TriLink BioTechnologies (TriLink®), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has announced the grand opening of its new
Apr 10, 2024 04:05 pm ET
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024
Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its first quarter 2024 financial and operating results after the market closes on...
Mar 12, 2024 04:15 pm ET
Maravai LifeSciences Announces March 2024 Investor Conference Schedule
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conference during the month of March. On March 19,...
Feb 23, 2024 08:31 am ET
Thinking about buying stock in Maravai Lifesciences, Abercrombie & Fitch, elf Beauty, IONQ, or Vanda Pharmaceuticals?
NEW YORK, Feb. 23, 2024 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MRVI, ANF, ELF, IONQ, and VNDA.
Feb 22, 2024 04:05 pm ET
Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the fourth quarter and full year ended December 31,...
Feb 21, 2024 08:00 am ET
TriLink BioTechnologies® Solidifies IP Position with Awarded Patents for CleanCap® Capping Technology in China and Canada
TriLink BioTechnologies (TriLink®), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has been granted patents by the China National Intellectual Property Administration (CNIPA) and the Canadian Intellectual Property Office (CIPO). Patent numbers ZL 2023 1 0
Feb 13, 2024 08:30 am ET
Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing
Dyadic International Inc. (“Dyadic”, or the “Company”) (Nasdaq: DYAI) and Cygnus Technologies®, part of Maravai LifeSciences® (Nasdaq: MRVI), announced today a strategic partnership for the quantification of Host Cell Proteins (“HCP”) from the...
Jan 29, 2024 08:00 am ET
Maravai LifeSciences To Host Earnings Conference Call on Thursday, February 22, 2024
Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its fourth quarter and full year 2023 financial and operating results after the...
Nov 09, 2023 08:15 am ET
Maravai LifeSciences Announces November 2023 Investor Conference Schedule
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conferences during the month of November. On November...
Nov 07, 2023 04:05 pm ET
Maravai LifeSciences Reports Third Quarter 2023 Financial Results
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the third quarter ended September 30, 2023, together...
Nov 02, 2023 06:47 am ET
TriLink BioTechnologies® Expands Capabilities with Launch of ‘Analytical Sciences Center of Excellence’
TriLink BioTechnologies® (TriLink), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has launched its Analytical Sciences Center of Excellence (ASCE) hub. Expanding its comprehensive suite of analytical testing capabilities, this new center of excellence will minimize the de
Oct 17, 2023 08:15 am ET
Maravai LifeSciences To Host Earnings Conference Call on Tuesday, November 7, 2023
Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its third quarter 2023 financial and operating results after the market closes on...
Sep 29, 2023 08:15 am ET
Maravai LifeSciences Hosts 2023 Investor R&D Day
Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, hosted its 2023 Investor R&D Day featuring presentations by Trey Martin,...
Sep 19, 2023 09:31 am ET
Maravai LifeSciences Chief Innovation Officer Kate Broderick Named to 2023 PharmaVoice 100
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that Chief Innovation Officer Kate Broderick, PhD, has been named to the 2023 PharmaVoice 100...
Sep 05, 2023 04:15 pm ET
Maravai LifeSciences to Host 2023 Investor R&D Day
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced that it will host its 2023 Investor R&D Day on Thursday, September 28, starting...
Aug 23, 2023 08:15 am ET
Cygnus Technologies Receives 2023 R&D 100 Award for MockV® RVLP Kit
Cygnus Technologies, part of Maravai LifeSciences (Maravai) (NASDAQ: MRVI), the leading product and services provider for the detection and characterization of process-related impurities in biopharmaceuticals, received a 2023 R&D 100 Award from R&D...
Aug 09, 2023 04:15 pm ET
Maravai LifeSciences Announces August 2023 Investor Conference Schedule
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conference during the month of August. On August 16,...
Aug 07, 2023 04:05 pm ET
Maravai LifeSciences Reports Second Quarter 2023 Financial Results
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the second quarter ended June 30, 2023, together with...
Jul 27, 2023 04:05 pm ET
Maravai LifeSciences Announces Completion of Planned CEO Leadership Transition
Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced that William “Trey” Martin, III has assumed the role of Chief...
Jul 24, 2023 04:05 pm ET
Maravai LifeSciences To Host Earnings Conference Call on Monday, August 7, 2023
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter 2023 financial and operating results after the market...
Jul 20, 2023 04:05 pm ET
Maravai LifeSciences Announces Appointment of New Director to the Board
Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced that Robert (“Chip”) Hance has stepped down from the Company’s...
Jun 06, 2023 08:00 am ET
Congressman Scott Peters Tours Maravai’s RNA manufacturing facility
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, recently hosted Congressman Scott Peters for a tour of the RNA manufacturing facility at Wateridge Circle in...
May 24, 2023 08:10 am ET
TriLink BioTechnologies® Announces Manufacturing Capabilities Expansion as mRNA Manufacturing Facility Nears Completion
TriLink has reliably delivered GMP services to its customers since the debut of its first cGMP manufacturing facility in 2015. Built to meet the need of a rapidly growing market, the new cGMP facility is expected to contribute to the development of vital mRNA therapeutics. The building has been designed for the cGMP manufacture of mRNA-based in vivo gene editing, gene-edited cell therapies, protein replacement therapies, cancer vaccines, and infectious disease vaccines.
May 09, 2023 08:00 am ET
TriLink BioTechnologies Introduces Latest mRNA Capping Technology: CleanCap® M6 analog
TriLink BioTechnologies (TriLink), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has launched its newest cap analog, CleanCap® M6 . The latest CleanCap analog is expected to help developers...
May 08, 2023 04:05 pm ET
Maravai LifeSciences Reports First Quarter 2023 Financial Results
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the first quarter ended March 31, 2023, together with...
Apr 17, 2023 04:15 pm ET
Maravai LifeSciences To Host Earnings Conference Call on Monday, May 8, 2023
Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its first quarter 2023 financial and operating results after the market closes on...
Mar 28, 2023 05:00 pm ET
Maravai LifeSciences Releases 2022 Environmental, Social and Governance (ESG) Report
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced the release of its second Environmental, Social and Governance (ESG)...
Mar 08, 2023 08:00 am ET
Maravai LifeSciences Announces March 2023 Investor Conference Schedule
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conferences during the month of March. On March 15,...
Feb 22, 2023 04:05 pm ET
Maravai LifeSciences Reports Fourth Quarter and Full Year 2022 Financial Results
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the fourth quarter and full year ended December 31,...
Feb 01, 2023 08:00 am ET
Maravai LifeSciences to Host Earnings Conference Call on Wednesday, February 22, 2023
Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its fourth quarter and full year 2022 financial and operating results after the...
Dec 01, 2022 04:01 pm ET
Maravai LifeSciences Announces Updated CEO Leadership Transition Plans
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced plans for William “Trey” Martin, III to serve as President of Maravai’s Biologics Safety Testing...
Nov 16, 2022 05:05 pm ET
Maravai LifeSciences Named to the 2022 Deloitte Technology Fast 500™ List of Fastest-Growing Companies in North America
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced it ranked 270 on the Deloitte Technology Fast 500™, a ranking of the 500 fastest-growing...
Nov 07, 2022 04:10 pm ET
New Kit Predicts Retroviral Particle Clearance in Biopharmaceutical Manufacturing
Cygnus Technologies, part of Maravai LifeSciences (Maravai) (NASDAQ: MRVI), the leading assay and services provider for the detection and characterization of process-related impurities in biopharmaceuticals, announced today the launch of the MockV®...
Nov 03, 2022 04:05 pm ET
Maravai LifeSciences Announces November and December 2022 Investor Conference Schedule
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conferences during the months of November and December....
Nov 02, 2022 04:05 pm ET
Maravai LifeSciences Reports Third Quarter 2022 Financial Results
Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the third quarter ended September 30, 2022, together...
Oct 19, 2022 08:10 am ET
Maravai LifeSciences Temporarily Reinstates Carl Hull as CEO Amidst Pending Noncompetition Litigation
Executive Chairman and former CEO of Maravai LifeSciences, Inc. (NASDAQ: MRVI) Carl Hull, has been reinstated as CEO of the company on an interim basis. Three subsidiaries of Danaher Corporation, two of which previously employed recently-appointed...
Oct 18, 2022 04:15 pm ET
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 2, 2022
Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its third quarter 2022 financial and operating results after the market closes on...
Oct 03, 2022 04:05 pm ET
Maravai LifeSciences Announces CEO Leadership Transition
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced today that its Board of Directors has appointed William “Trey” Martin, III as its chief executive...

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.